RFP Expressing Human MDA-MB-231 Breast Cancer Cells
Quick Actions
Product Overview
Description
The MDA-MB-231 Breast Cancer Cells, which express red fluorescent protein (RFP), exhibit a vibrant fluorescence that allows for easy visualization and analysis in research applications.
IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.
Key Features
Catalog Number: NBP-0034-RFP
Product Format: Frozen
Vial Cell Number: > 5x10[5] cells/vial
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RUO)
Characteristics:
-Human Breast Adenocarcinoma cell line
-Triple-negative breast cancer phenotype
-RFP fluorescence for red-channel imaging
-Aggressive and invasive cancer cell model
-Mesenchymal-like morphology
-Suitable for migration, invasion, proliferation, and drug-response assays
-Compatible with 2D monolayer culture and 3D spheroid/tumor models
Quick Facts
Product Type
Tumor Cells
Viability
>95% viable (Trypan Blue exclusion)
Applications
-Triple-negative breast cancer research -Tumor m…
Availability
In Stock • Global Shipping
Technical Specifications
Primary Applications
Applications & Use Cases
Primary Applications
-Triple-negative breast cancer research -Tumor migration and invasion assays -Live-cell fluorescence imaging -2D and 3D tumor spheroid models -Drug screening and cytotoxicity studies
Suitable for -triple-negative breast cancer research -tumor migration and invasion assays -live-cell fluorescence imaging -2d and 3d tumor spheroid models -drug screening and cytotoxicity studies studies and research applications
Research Areas
In Vitro Studies
Cell culture and screening applications
Molecular Biology
Gene expression & signaling studies
Drug Discovery
Screening & validation studies
Disease Modeling
Pathophysiology research
Support & Resources
Technical Support
Our experts are available for technical questions and protocol assistance.
Contact Support
